International, multicenter, prospective and observational registry. Evaluation of safety and efficacy of Angiolite drug eluting stent in non-selected patients from the clinical daily practice.
DESCRIPTION
Device
Angiolite
Number of patients
646
Follow up
5 years. Latest outcomes at 3 years
Type of lesions
Non-selected, real world population
OUTCOMES
Primary outcome
Consitently low rate of TLF
Angiolite demonstrates high efficacy
Secondary outcomes
No late ST after 6 months
Angiolite warrantees its safe use
A. Perez de Prado et. al. REC: Interv. Cardiol. 2021. In Press
CONCLUSIONS
“Angiolite demonstrates an outstanding safety and efficacy profile even in high risk population”
In conclusion, the results of this observational registry on the use of the Angiolite DES in a real-world population confirm the excellent efficacy and safety profile seen in previous studies at the 2-year follow-up. An extended 5-year follow-up is planned to discard late events.
The publication of RANGO Registry 2 years outcomes is available here.
MAIN INVESTIGATOR
Dr A. Pérez de Prado
Hospital and University of León (León, SPA)
